These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30045610)

  • 41. The Effect of Epidural Steroid Injections on Bone Mineral Density and Vertebral Fracture Risk: A Systematic Review and Critical Appraisal of Current Literature.
    Kerezoudis P; Rinaldo L; Alvi MA; Hunt CL; Qu W; Maus TP; Bydon M
    Pain Med; 2018 Mar; 19(3):569-579. PubMed ID: 29304236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study.
    Creatsa M; Pliatsika P; Kaparos G; Antoniou A; Armeni E; Tsakonas E; Panoulis C; Alexandrou A; Dimitraki E; Christodoulakos G; Lambrinoudaki I
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1415-22. PubMed ID: 21651652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids.
    Ebeling PR; Erbas B; Hopper JL; Wark JD; Rubinfeld AR
    J Bone Miner Res; 1998 Aug; 13(8):1283-9. PubMed ID: 9718197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefit period using alendronate to increase bone mineral density in women with osteoporosis?
    Ozdemir F; Rodoplu M
    Chin Med J (Engl); 2005 Mar; 118(5):383-90. PubMed ID: 15780207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
    Park SY; Ahn SH; Bae GH; Jang S; Kwak MK; Kim HY; Kim SH;
    Osteoporos Int; 2024 Oct; 35(10):1779-1787. PubMed ID: 38953946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Influence on adjacent lumbar bone density after strengthening of T12, L1 segment vertebral osteoporotic compression fracture by percutaneous vertebroplasty and percutaneous kyphoplasty].
    Zhang C; Zhu K; Zhou J; Zhou X; Niu G; Wu M; Shao C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):819-23. PubMed ID: 24063170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial.
    Mok CC; Ying KY; To CH; Ho LY; Yu KL; Lee HK; Ma KM
    Ann Rheum Dis; 2011 May; 70(5):778-84. PubMed ID: 21187295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.
    Emkey R; Delmas PD; Goemaere S; Liberman UA; Poubelle PE; Daifotis AG; Verbruggen N; Lombardi A; Czachur M
    Arthritis Rheum; 2003 Apr; 48(4):1102-8. PubMed ID: 12687554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of parity on bone mineral density among postmenopausal Saudi Arabian women.
    Sadat-Ali M; Al-Habdan I; Al-Mulhim AA; El-Hassan AY
    Saudi Med J; 2005 Oct; 26(10):1588-90. PubMed ID: 16228061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
    Brixen K; Chapurlat R; Cheung AM; Keaveny TM; Fuerst T; Engelke K; Recker R; Dardzinski B; Verbruggen N; Ather S; Rosenberg E; de Papp AE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):571-80. PubMed ID: 23337728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients.
    van den Ham EC; Kooman JP; Christiaans ML; van Hooff JP
    Transpl Int; 2003 Feb; 16(2):82-7. PubMed ID: 12595969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
    Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
    J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The skeletal consequences of epidural steroid injections: a literature review.
    Krez A; Liu Y; Kanbour S; Clare S; Waldman S; Stein EM
    Osteoporos Int; 2021 Nov; 32(11):2155-2162. PubMed ID: 34089066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tibolone and osteoporosis.
    Lazovic G; Radivojevic U; Milosevic V; Lazovic A; Jeremic K; Glisic A
    Arch Gynecol Obstet; 2007 Dec; 276(6):577-81. PubMed ID: 17605023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Kim H; Baek KH; Lee SY; Ahn SH; Lee SH; Koh JM; Rhee Y; Kim CH; Kim DY; Kang MI; Kim BJ; Min YK
    Osteoporos Int; 2017 Mar; 28(3):1099-1108. PubMed ID: 27866216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.
    Bone HG; Bolognese MA; Yuen CK; Kendler DL; Miller PD; Yang YC; Grazette L; San Martin J; Gallagher JC
    J Clin Endocrinol Metab; 2011 Apr; 96(4):972-80. PubMed ID: 21289258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Clin Exp Rheumatol; 2003; 21(2):155-60. PubMed ID: 12747268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.